Trust Co. of Vermont grew its holdings in shares of McKesson Co. (NYSE:MCK – Free Report) by 7.8% in the 3rd quarter, ...

This has lagged the Medical sector's loss of 2.27% and the S&P 500's gain of 1.71% in that time. Analysts and investors alike will be keeping a close eye on the performance of McKesson in its ...

McKesson Co. (NYSE:MCK – Get Free Report) has earned an average recommendation of “Moderate Buy” from the sixteen brokerages ...

The Zacks Medical - Dental Supplies industry, to which McKesson belongs, has lost 0.7% over this period. Now the key question is: Where could the stock be headed in the near term? While media ...

Furthermore, Coldwell notes that McKesson’s practice of providing guidance and explanations has become more opaque, especially in relation to its Medical-Surgical and Prescription Technology ...

not keeping up with the Medical sector's loss of 3.6% and the S&P 500's gain of 1.21%. The investment community will be paying close attention to the earnings performance of McKesson in its ...

Baird downgraded medical distributor McKesson (NYSE:MCK) to neutral from outperform on Tuesday, calling the company's plans to conduct an investor event with the sell-side community "unusual." ...

Shares of McKesson (MCK) are oversold. They are also at a potential support level. Stocks that are oversold and at support tend to rally. The best traders traders focus on key price levels and ...

Additionally, Hill’s optimism seems to be fueled by McKesson’s guidance, which suggests significant growth potential in its Prescription Technology Solutions (RxTS) and Medical segments.